On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about ...

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent ...

The world’s foremost influenza experts know remarkably little; they have not even known that flu was a virus for very long. To inform us about its evolutionary history, its human history and what it ...

Lead researcher and CEO of POP Biotechnologies, Dr. Jonathan Lovell is based at the University at Buffalo. Dr. Lovell said ...

Canada is just emerging from another winter wave of multiple infectious diseases only for the population to be confronted ...

European health authorities agree with Donald Trump’s health secretary on some big picture issues - but not on all the ...

In influenza vaccination, PFSs may cost more per dose than multidose vials (MDVs), but could offer advantages in speed, disposal, wastage and patient safety owing to premeasured accurate doses ...

vaccine candidate, ARCT-2304, for active immunization to protect against the influenza A H5N1 virus. The Fast Track designation from the FDA facilitates rapid development and expedites the review ...